[
    "1.",
    "Separate Hela nuclear proteins into nuclear extracts and nuclear pellets using a previously described procedure \\(Dignam, 1983). \r\n  ",
    "2. Load the Nuclear ",
    "Extract \\(6 g) onto a 700 ml P11 column equilibrated with buffer C \\(20 mM",
    "Tris-HCl, pH 7.9, 0.2 mM EDTA, 1 mM DTT, 0.1 mM PMSF, 0.025 % NP-40, 10 % glycerol) containing 100 mM KCl \\(BC100). \r\n  ",
    "3.Step ",
    "Elute proteins that bound to the column with BC300, BC500, and BC1000. ",
    "4. Dialyze the BC500 fraction against Buffer D \\(40 mM Hepes-KOH, pH 7.9, 0.2 mM EDTA, 1 mM DTT, 0.1 mM PMSF, 0.025 % NP-40, 10 % glycerol) containing 20 mM ammonium sulfate \\(BD20) and then ",
    "Load onto a 45 ml HPLC-DEAE-5PW column \\(TOSOH Bioscience). \r\n  ",
    "5. Elute bound proteins with an 8 column volume \\(cv) linear gradient from BD20 to BD500. \r\n  ",
    "6.",
    "Adjust fractions that contain H2A-deubiquitination activity to BD600 with saturated ammonium sulfate and loaded onto a 22 ml FPLC Phenyl Sepharose column \\(Amersham Biosciences).",
    "Bound proteins were eluted with a 12 cv linear gradient from BD600 to BD0.  \r\n  ",
    "7. Apply the active fractions to a Sephacryl S-300 column \\(Amersham Biosciences).",
    "The H2A-deubiquitination activity eluted between 443-670 kDa. \r\n  ",
    "8.",
    "Dialyze these fractions against buffer P \\(5 mM Hepes-KOH, pH 7.5, 0.04 M KCl, 0.01 mM CaCl2, 10 % glycerol, 1 mM DTT, 0.1 mM PMSF) containing 10 mM potassium phosphate and ",
    "Load onto a 1 ml hydroxyapatite column \\(Bio-rad). \r\n  ",
    "9.",
    "Elute the column with a 20 cv linear gradient from BP10 to BP600. \r\n  ",
    "10.",
    "Load fractions that contain H2A-deubiquitination activity onto a Superose 6 column \\(Amersham Biosciences) equilibrated with BC500.",
    "UBp-M eluted between 443-670 kDa."
]